Skip to content
‹ Back to IndustriesSciences

Why Removing Dead Trees is Vital for Storm Safety

Removing dead trees is crucial for storm safety due to their potential to cause property damage and injury. Expert James Allen advises immediate removal to prevent risks associated with falling limbs and total tree failure. Factors like surrounding environments are crucial in assessing danger levels during storms.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sunny Crutchfield · · ArboristDead TreesDfw Tree Care ServicesDying Trees
Share
Why Removing Dead Trees is Vital for Storm Safety

Key takeaways

01

Dead trees present significant hazards during severe weather events.

02

Immediate removal of dead trees is advised to prevent property damage and injury.

03

Experts must consider the surrounding environment in assessing tree danger levels.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

In this informative video, ISA Certified Arborist James Allen delves into the critical reasons behind the swift removal of dead trees. The discussion centers on the inherent hazards these trees pose to both property and people. James stresses the urgency of this process, emphasizing that delaying removal increases the risk of falling limbs, potential total tree failure, and heightened liability. The insightful narration underscores the importance of expert recommendations for immediate action. Using a tangible example of a looming dead tree, the video elucidates how the danger level is evaluated based on the surroundings. Factors such as nearby fences, pristine yards, and the potential for foot traffic or vehicles passing through are all considered. The conclusion is clear: swift removal of the dead tree is essential to prevent damage to property and ensure the safety of individuals in its vicinity.

Discover more reasons why working with an arborist can safeguard the future of your trees!

Are you looking for a sustainable Dallas-Fort Worth tree care company that prioritizes the health and longevity of your North Texas trees and landscapes?

Look no further than TreeNewal, your trusted partner in tree care.

Our team of ISA Certified Arborists is dedicated to providing comprehensive tree services that ensure the vitality of your trees. From maintaining and reviving newly planted and established trees to diagnosing and treating tree diseases, fungi, and pests, we have you covered.

We specialize in proper tree diagnosis and offer tailored maintenance and treatment plans to keep your trees thriving. Our experts apply top-quality fertilizer and soil conditioning products to enhance tree health from the roots up.

At TreeNewal, we understand that many trees suffer from improper planting practices. That’s why we offer specialized techniques such as air spading, root collar excavation, and vertical mulching to improve the longevity of your trees. Our goal is to create sustainable landscapes that stand the test of time.

We also provide tree surveys and mitigation services to assist homeowners, developers, and commercial clients in meeting local city tree preservation requirements. With our expertise, you can ensure compliance while preserving the natural beauty of your surroundings.

Call TreeNewal today to schedule a consultation with our knowledgeable team. Let us be your partners in preserving the beauty and longevity of your beloved trees.

Contact TreeNewal now and experience exceptional tree care services!

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

Sunny Crutchfield
Sunny CrutchfieldDigital Media Strategist

Throughout her career, Sunny Crutchfield has honed her skills in crafting data-driven campaigns, maximizing social media presence, and optimizing online content for optimal engagement and conversions. Her deep understanding of various digital channels, including social media, search engine marketing, email marketing, and content marketing, allows her to develop comprehensive and integrated campaigns that deliver tangible results.

B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Antibody developability checks are moving into discovery instead of waiting for development

Antibody developability checks are moving into discovery instead of waiting for development

Maria Gonzalez-Pajuelo of FairJourney Bio says the order in antibody discovery is changing: developability has become a much more important consideration during discovery, rather than an issue left until later-stage development. The goal, she says, is that what comes out of discovery is something CMC can take forward easily.

  • 01Discovery-stage developability screens can rank many antibodies tested once or twice and may reduce surprises later in development, while development still focuses on several lots of a single antibody and answers different questions.

Oct 1, 2026

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

ISPE’s 2026 Annual Meeting and Expo in Washington, DC organizes its program around five tracks running from discovery to governance, with international program committee chair Connie Langer of Pfizer Global Supply and executive chair Jose Caraballo of JCO Global Advisory LLC describing how the tracks connect—and why AI is treated as a cross-cutting topic rather than a standalone track. Deloitte’s December 2025 survey of 280 executives frames the mood the program is built for.

  • 01ISPE’s 2026 Annual Meeting has no dedicated AI track; executive chair Jose Caraballo expects AI presentations across all five tracks, from discovery to governance.
  • 02Deloitte’s December 2025 survey of 280 biopharma and medtech C-suite executives found more than 75% confident in their own outlook but only 41% optimistic about the global economy, a mood the story says the ISPE chairs are programming for.
  • 03A staffing firm reports life sciences job openings falling even as digital fluency becomes a required skill, so the upskilling burden lands on the people already employed, which is where the mandatory, university-partnered AI training Connie Langer describes at her company sits.

Sep 30, 2026

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site designs preclinical tumor models to match specific therapies and delivery routes, rather than forcing treatments into standard study designs. It combines custom surgical procedures, cell line-derived xenografts, patient-derived xenografts (including post-treatment models), and biomarker capabilities to generate translational data that can help sponsors decide whether to advance a program.

  • 01Orthotopic brain tumor implantation using tagged models lets researchers track tumor growth in the original organ, aligning the model and delivery route with how therapies are intended to be tested.
  • 02Patient-derived xenografts developed from tumors after prior treatment may better reflect progressed disease, helping teams study therapies aimed at patients whose cancer has advanced after earlier treatment.
  • 03Combining biomarker analysis of preclinical model samples with clinical sample testing at one site could make it easier to connect what is measured in animals with what is later measured in patients.

Sep 30, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Experts

Sunny Crutchfield
Sunny Crutchfield

Digital Media Strategist

Throughout her career, Sunny Crutchfield has honed her skills in crafting data-driven campaigns, maximizing social media presence, and optimizing online content for optimal engagement and conversions. Her deep understanding of various digital channels, including social media, search engine marketing, email marketing, and content marketing, allows her to develop comprehensive and integrated campaigns that deliver tangible results.

JA
James Allen

ISA Certified Arborist

TreeNewal

ISA Certified Arborist at TreeNewal, focusing on comprehensive tree care services, including tree diagnosis and treatment.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512